Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Alphabet's unprofitable Verily unit in skin-care deal with L'Oreal

Stock MarketsJan 20, 2022 05:11PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. A L'Oreal logo is seen at the company's offices in Levallois-Perret, near Paris, France, May 7, 2021. REUTERS/Christian Hartmann

By Paresh Dave

(Reuters) -Alphabet Inc's money-losing health tech arm Verily on Thursday announced a new tie-up in its search for sustainable revenue, saying it would study skin health and explore new products with cosmetics maker L'Oreal SA.

The company declined to disclose terms of what it called a "strategic, multi-year partnership and research collaboration" with L'Oreal.

Executives who have left Verily have criticized it for signing flashy, one-off research collaborations with pharmaceutical companies instead of focusing more attention on landing recurring subscribers to its software for clinical research and disease management.

The critics have said Verily's approach has left it with intermittent revenue and further off from generating profit.

Dr. Amy Abernethy, president of Verily's clinical research platforms, said the company's technology will underpin a longitudinal examination into skin issues and environments and behaviors possibly affecting them. Results could aid development of diagnosis and treatment options.

Abernethy, who has worked closely with skin cancer patients, noted that existing technology struggles to differentiate between similar-looking skin conditions.

By working together, the companies' aim is to "power every single person with access to the most inclusive and personalized information on their skin management," said Barbara Lavernos, deputy chief executive officer at L'Oreal.

Verily last year booked about $400 million in revenue, according to a source briefed on the figures. Over a quarter of sales came from the low-profit-margin business of administering COVID-19 tests for outside organizations, and Verily's overall losses widened significantly from 2020, the source said.

Verily said those numbers are inaccurate. It does not publicly report financial results.

Plans for the L'Oreal project include both the long-term software component and co-development of a new telecare service for dermatologists and consumers. The deal is Verily's first with a beauty company and follows years of talks with L'Oreal.

Corporate sibling Google (NASDAQ:GOOGL), which is testing an artificial intelligence tool for identifying skin conditions https://www.reuters.com/article/ctech-us-tech-fitzpatrick-exclusive-idCAKCN2DU0UA-OCATC, is not involved, executives said.

Verily's deal follows a similar partnership unveiled last August with Colgate-Palmolive (NYSE:CL) Co to study oral health.

Alphabet's unprofitable Verily unit in skin-care deal with L'Oreal
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email